Fish Oil for IgA Nephropathy?

A quarter of a century ago, Jean Berger, using recently developed immunofluorescence methods, discovered diffuse mesangial deposits of IgA on light microscopy of kidneys with focal, glomerular lesions.1 IgA nephropathy is now the most common form of glomerulonephritis throughout the world, accounting for up to 10 percent of patients treated for end-stage renal disease.2 Patients with IgA nephropathy have better long-term outcomes than those with other forms of glomerulonephritis; their frequency of end-stage renal disease is 13 to 20 percent 10 years after diagnosis and 25 to 34 percent 20 years after diagnosis.3 As in most other forms of glomerulonephritis, . . .